Postmenopausal women with osteoporosis may be associated with high endothelin-1

References

• von Schroeder H P, Veilette C J, Payandeh J, Qureshi A, Heersche J N. Endothelin-1 promotes osteoprogenitor proliferation and differentiation in fetal rat calvarial cell cultures. Bone 2003; 33: 673–684
   Google Scholar
• Tatrai A, Stern P H. Endothelin-1 modulates calcium signaling by epidermal growth factor, alpha-thrombin, and prostaglandin E1 in UMR-106 osteoblastic cells. J Bone Miner Res 1993; 8: 943–952
   Google Scholar
• Windischhofer W, Zach D, Fauler G, Raspotnig G, Kofeler H, Leis H J. Involvement of Rho and p38 MAPK in endotelin-1-induced expression of PGHS-2 mRNA in osteoblast-like cells. J Bone Miner Res 2002; 17: 1774–1784
   Google Scholar
• Hierl T, Borcsok I, Sommer U, Ziegler R, Kasperk C. Regulation of interleukin-6 expression in human osteoblastic cells in vitro. Exp Clin Endocrinol Diabetes 1998; 106: 324–333
   PubMed Web of Science ®Google Scholar
• Helfrich M H, Evans D E, Grabowski P S, Pollock J S, Ohshima H, Ralston S H. Expression of nitric oxide synthase isoforms in bone and bone cell cultures. J Bone Miner Res 1997; 12: 1108–1115
   PubMed Web of Science ®Google Scholar
• Hukkanen M V, Platts L AM, Fernandez de Marticorena I, et al. Developmental regulation of nitric oxide synthase expression in rat skeletal bone. J Bone Miner Res 1999; 14: 868–877
   Google Scholar
• Lu R, Hu C P, Wu X P, Liao E Y, Li Y J. Effect of age on bone mineral density and the serum concentration of endogenous nitric oxide synthase inhibitors in rats. Comp Med 2002; 52: 224–228
   Google Scholar
• Peng W J, Jiang J L, Jia S J, Li D, Zhang X J, Luo D, Liao E Y, Deng H W, Li Y J. Asymmetric dimethylarginine is not involved in ovariectomy-induced osteopenia in rats. Comp Med 2005; 55: 30–33
   Google Scholar
• Muratli H H, Celebi L, Hapa O, Biçimoğlu A. Comparison of plasma endothelin levels between osteoporotic, osteopenic and normal subjects. BMC Musculoskelet Disord 2005; 6: 49
   Google Scholar
• Moldes O, Sobrino T, Millán M, Castellanos M, Pérez de la Ossa N, Leira R, Serena J, Vivancos J, Dávalos A, Castillo J. High serum levels of endothelin-1 predict severe cerebral edema in patients with acute ischemic stroke treated with t-PA. Stroke 2008; 39: 2006–2010
   PubMed Web of Science ®Google Scholar
• Schulze F, Wesemann R, Scwedhelm E, Arakawa N, Sydow K, Albsmeier J, Ooke J P, Boger R H. Determination of asymmetric dimethylarginine (ADMA) sing a novel ELISA assay. Clin Chem Lab Med 2004; 42: 1377–1383
   PubMed Web of Science ®Google Scholar
• Schulze F, Maas R, Freese R, Schwedhelm E, Simberhorn E, Boger R H. Determination of a reference value for NG, NG-dimethyl-l-arginine in 500 subjects. Eur J Clin Invest 2005; 35: 622–626
   PubMed Web of Science ®Google Scholar
• Alam A S, Gallagher A, Shankar V, Ghatei M A, Datta H K, Huang C L, Moonga B S, Chambers T J, Bloom S R, Zaidi M. Endothelin inhibits osteoclastic bone resorption by a direct effect on cell motility: implications for the vascular control of bone resorption. Endocrinology 1992; 130: 3617–3624
   PubMed Web of Science ®Google Scholar
• Zaidi M, Alam A S, Bax B E, Shankar V S, Bax C M, Gill J S, Pazianas M, Huang C L, Sahinoglu T, Moonga B S. Role of the endothelial cell in osteoclast control: new perspectives. Bone 1993; 14: 97–102
   PubMed Web of Science ®Google Scholar
• Haenggi W, Bersinger N A, Mueller M D, Birkhaeuser M H. Decrease of serum endothelin levels with postmenopausal hormone replacement therapy or tibolone. Gynecol Endocrinol 1999; 13: 202–205
   PubMed Web of Science ®Google Scholar
• Altavilla D, Crisafulli A, Marini H, Esposito M, D'Anna R, Corrado F, Bitto A, Squadrito F. Cardiovascular effects of the phytoestrogen genistein. Curr Med Chem Cardiovasc Hematol Agents 2004; 2: 179–186
   PubMedGoogle Scholar
• Takuwa Y, Ohue Y, Takuwa N, Yamashita K. Endothelin-1 activates phospholipase C and mobilizes Ca from extra and intracellular pools in osteoblastic cells. Am J Physiol 1989; 257: E797–E803
   PubMed Web of Science ®Google Scholar
• Kasperk C H, Borcsok I, Schairer H U, Schneider U, Nawroth P P, Niethard F U, Ziegler R. Endothelin-1 is a potent regulator of human bone cell metabolism in vitro. Calcif Tissue Int 1997; 60: 368–374
   PubMed Web of Science ®Google Scholar
• Leis H J, Zach D, Huber E, Windischhofer W. Prostaglandin endoperoxide synthase-2 contributes to the endothelin/sarafotoxin-induced prostaglandin E2 synthesis in mouse osteoblastic cells (MC3T3-El): evidence for a protein tyrosine kinase-signaling pathway and involvement of protein kinase C. Endocrinology 1998; 139: 1269–1277
   Google Scholar
• von der Recke P, Hansen M A, Hassager C. The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 1999; 106: 273–278
   PubMed Web of Science ®Google Scholar
• Barengolts E I, Berman M, Kukreja S C, Kouznetsova T, Lin C, Chomka E V. Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women. Calcif Tissue Int 1998; 62: 209–213
   PubMed Web of Science ®Google Scholar
• Kiel D P, Kauppila L I, Cupples L A, Hannan M T, O'Donnell C J, Wilson P W. Bone loss and the progression of abdominal aortic calcification over a 25 year period: the Framingham Heart Study. Calcif Tissue Int 2001; 68: 271–276
   PubMed Web of Science ®Google Scholar
• Armour K E, Armour K J, Gallagher M E, Godecke A, Helfrich M H, Reid D M, Ralston S H. Defective bone formation and anabolic responses to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide sythase. Endocrinology 2001; 142: 760–766
   PubMedGoogle Scholar